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The most compelling evidence for the existence of tumor-specific antigens  (TSA) 1 
comes from the study of chemically induced tumors of inbred rodents. These tumors 
express antigens capable of immunizing syngeneic hosts against subsequent challenge 
with the same tumor. An intriguing feature of TSA of chemically induced tumors is 
their uniqueness, each tumor having a  distinct antigen (1-3). No cross-reactions are 
observed between tumors induced by the same carcinogen, even if they are induced 
in the same animal  (4).  In vitro transformed cell populations, recently derived from 
a  single  clone,  express  TSA  that  are  still  non-cross-reactive  (5,  6).  TSA  appear 
simultaneously with the neoplastic transformation of the carcinogen-treated tissue (5, 
7, 8). Once expressed, TSA become a permanent trait of the tumor and remain stable 
through many transplantations in immunologically competent hosts or through serial 
passages in vitro (3). Tumors induced by different carcinogens differ in their immu- 
nogenicity. The strong TSA of 3-methylcholanthrene (MCA)-induced sarcomas made 
them preferred objects of immunologic studies and much of the present knowledge on 
TSA is based on the work with MCA-induced tumors. 
Nothing is known about the location, the number, and the nature of genes coding 
for TSA.  The assignment  of TSA to particular chromosomes through somatic cell 
genetics techniques would be a  step  toward elucidating the genetic basis of tumor 
antigen diversity. More specifically, two questions could be addressed through  this 
methodology: (a) are TSA coded by different, random loci, or are they coded by one 
or a  few specific genes with high mutability or with antigenically diverse products? 
and  (b)  are TSA loci linked to genes (such as the H-2 complex) known to code for 
molecules with considerable antigenic variability? 
To facilitate analysis of the TSA of chemically induced tumors, much effort has 
gone into developing serological reagents to detect these antigens. In most instances, 
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it has not been possible to demonstrate antibody with specificity for individual tumors 
in the serum of immunized mice, despite prolonged immunization and a high level of 
resistance  to  tumor  transplants.  Recently,  however,  DeLeo  et  al.  (9)  were  able  to 
produce syngeneic antiserum that defined a  cell surface antigen restricted to a  single 
MCA-induced  BALB/c  sarcoma,  Meth  A.  There  is  growing  evidence  that  the 
serologically defined  Meth  A  antigen  is related  to  the strong,  individually distinct 
transplantation antigen expressed by Meth A  (10). 
The  present  study  was  aimed  at  mapping  the  genetic  locus  of the  serologically 
defined Meth A  antigen through the use of somatic cell hybrids. 
Materials  and  Methods 
Cell Lines.  Meth A is a strongly immunogenic sarcoma induced in 1960 by a subcutaneous 
injection of MCA in a BALB/c female mouse (3). An ascites variant of the tumor was derived 
in 1961. The two cell lines used in the present study, Meth A(a) and Meth A(s), were established 
in 1974 from the ascitic and solid forms of the tumor, respectively (9). E36 is an established line 
of Chinese hamster lung cells, derived from V79 (11). The clone used in the present study is a 
hypoxanthine ~hosphoribosyl transferase (HPRT-) mutant resistant to 30 #g/ml 6-thioguanine 
and to 3 ×  I0-  M  ouabain. These cells show no density dependent inhibition of growth. THO 
is an HPRT- clone of BALB/3T3 cells (12), resistant to 6/~g/ml 6-thioguanine. All cells were 
maintained in Dulbecco's modified Eagle medium with 10% fetal calf serum. 
Typing Sera  for Meth A Antigen.  Antisera detecting the Meth A  antigen were produced by 
immunization of BALB/c or (BALB/c ×  C57B16)  FI mice as described (9).  These antisera 
have cytotoxic antibody that defines a  TSA on BALB/c Meth A  sarcoma. The serologically 
defined Meth A antigen is stably expressed by the ascitic and solid forms of Meth A, as well as 
by cell lines derived from them. Absorption studies indicate that expression of this antigen is 
restricted to  Meth  A. The  antigen  has not  been  detected on  a  wide range of normal and 
malignant cells derived from BALB/c or from other strains of mice. 
Serological Analysis.  The hybrids were analyzed for Meth A antigen expression by absorption 
tests  (9).  The  dilution of antiserum chosen  for absorption tests was generally one doubling 
dilution below its endpoint  (50%  cytotoxieity), as determined in preliminary tests. 2  vot of 
diluted antiserum and  1 vol of packed, washed cells were incubated together, with frequent 
shaking, for 30 rain at 4°C. After removal of the absorbing cells by centrifugation, the residual 
cytotoxic activity of the absorbed antiserum was tested. 
Preparation of Microcells.  Cells were micronucleated by exposure to colcemid (Gibco Labo- 
ratories, Grand Island Biological Co., Grand Island, N. Y.)  at a  concentration of 0.05-0.075 
/xg/ml for 36-48 h  (13,  14). Enucleation of the microcells was carried out on a  discontinuous 
Ficoll (Ficoll 400; Pharmacia Fine Chemicals, Piscataway, N. J.) gradient after a modification 
of the protocol of Wigler and Weinstein (15). 
Cell Hybridization.  Whole cell and microcell Meth A(a) ×  E36 and Meth A(s) ×  E36 fusions 
were carried out with fl-propiolactone-inactivated Sendai virus. The microcell hybrids were 
selected and maintained on medium containing 10 -4 M hypoxanthine, 4 ×  10  -7 M aminopterin, 
and  1.6 ×  10  -s M  thymidine (HAT) (16). The whole cell hybrids were selected on HAT plus 
10  -3 M  ouabain. The hybrid series ma and mAE were produced from two separate hybridiza- 
tions  of Meth  A(a)-derived microcells with  E36.  Hybrids ms  were  isolated after fusion  of 
microcells from Meth A(s) with E36. Only clones picked from separate flasks were considered 
independent. 
lsozyme Analysis.  The  hybrids were analyzed for the presence of the mouse and Chinese 
hamster  forms  of the  following enzymes:  peptidase  3  (EC3.4.13),  peptidase  1  (EC3.4.13), 
nucleoside phosphorylase (EC2.4.2.1), phosphoglucomutase 1 (EC2.7.5.1), phosphoglucomutase 
2  (EC2.7.5.1),  peptidase 2  (EC3.4.13),  mannose  phosphate  isomerase  (EC5.3.1.8),  adenine 
phosphoribosyhransferase  (EC2.4.2.7),  uridine  phosphorylase  (EC2.4.2.3),  glyoxalase  1 
(EC4.4.1.5), galactokinase (EC2.7.1.6), malic enzyme (EC 1.1.1.39),  6-phosphogluconate dehy- 
drogenase  (EC1.1.1.43),  glucosophosphate  isomerase  (EC5.3.1.9),  glutathione  reductase 
(EC1.6.4.2),  triosophosphate  isomerase  (EC5.3.1.1),  esterase  10  (Esl0),  adenosine  kinase 966  GENETIC ANALYSIS OF TUMOR-SPECIFIC ANTIGENS 
(EC2.7.1.20),  acid phosphatase 1 (EC3.1.3.2),  a-galactosidase (EC3.2.1.22),  lactate dehydrogen- 
ase A (EC 1.1.1.27), and enolase (EC2.4.1.11).  The techniques for the enzyme assays have been 
described (17). 
Chromosome Analysis.  Chromosome preparations were G-banded after a modification of the 
method of Wang and Fedoroff (18). When necessary, additional C-banding techniques, barium 
hydroxide/saline/Giemsa  banding  (19) and  Hoechst  33258  staining  (20),  were  applied  to 
distinguish between Chinese hamster and grossly rearranged mouse chromosomes in the hybrid 
cells and to determine the position of centromeric heterochromatin in rearranged chromosomes. 
A minimum of 30 banded metaphases of each hybrid were karyotyped. In some cases,  up to 
200 additional cells were scanned microscopically for the presence of a particular chromosome 
previously identified by karyotyping. The nomenclature of Nesbitt and Francke (21) is used for 
the description of rearrangements involving mouse chromosomes. 
Results 
Eight  whole cell  hybrids  between  one  of the  Meth  A  sarcoma-derived  cell  lines, 
Meth  A(a),  and  the  Chinese  hamster  cell  line  E36  and  seven  hybrids  between  the 
other  Meth  A-derived line,  Meth  A(s), and  E36 were analyzed for Meth  A  antigen 
expression within the first five passages after their isolation. At that time, the hybrids 
had both the mouse and Chinese hamster forms of the 22 enzymes tested (assigned to 
14  mouse  chromosomes  and  to  an  unknown  number  of Chinese  hamster  chromo- 
somes). By karyotype analysis, the hybrids had a complete set of mouse chromosomes 
and >90% of the cells also had the complete set of E36 Chinese hamster chromosomes. 
All these hybrids expressed  Meth  A  antigens,  as indicated  by specific absorption  of 
typing serum  (Fig.  1A). 
To assign the gene coding for Meth A  antigen to a  particular chromosome, it was 
necessary to produce hybrid lines retaining  a  few mouse chromosomes on a  Chinese 
hamster background. The whole cell hybrids Meth A(a) ×  E36 and Meth A(s) X E36 
slowly segregated Chinese  hamster chromosomes and were thus unsuitable  for map- 
ping.  To circumvent  the species-determined  direction  of chromosome loss, we fused 
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E36 with microcells derived from Meth A(a) and Meth A(s), each microcell carrying 
an incomplete set of mouse chromosomes. 
A  total of 48 independent clones was isolated after two separate hybridizations of 
Meth A(a) microcells with E36 (hybrids ma and mAE) and one hybridization of Meth 
A(s) microcells with E36  (hybrids ms). The hybrids were analyzed for their isozyme 
content at the earliest possible time (during the first four passages).  35  (73%)  of the 
clones did not show any mouse isozymes. 21  of these lines were karyotyped and were 
found to  contain single mouse chromosomes or mouse chromosome fragments in a 
small fraction (1-10%) of the population. Thus, rapid chromosome loss and fragmen- 
tation  apparently  had  occurred  in  these  lines.  The  mouse  chromosome  segment 
carrying  the  gene  encoding  HPRT,  designated  hprt  +,  which  makes  possible  the 
survival of the  cells  in  HAT,  was  probably integrated somewhere  in  the  Chinese 
hamster genome. None of these hybrids expressed the Meth A  antigen. 
In 13 microcell hybrids, 1-4 mouse chromosomes were identified by karyotype and 
isozyme analysis. The results of the serologic and chromosome analysis of these hybrids 
are summarized in Table I. 
TABLE  I 
Results of the Serologic and Chromosome  Analysis of Meth A(a)  ×  E36 and Meth A(s)  X 
E36 Microcell Hybrids 
Percentage of  Meth A 
Hybrids/controls  Mouse chromosome present  cells with the  antigen 
chromosome  expression* 
ma 8c  X  TM  83  ++ 
ma 12  X  TM  75  ++ 
mAE 28  X  TM  50  ++ 
mAE 18  X 12  50  + 
mAE 6  1TM  70  ++ 
X 1  78 
mAE 17  6, 10, 12, 14, X$  70-85  + 
Ml, M2, Ma, M4 
mAE 12  del (X) (A7/B)  76  - 
ms 5  X  55  - 
mAE 19  1  68 
X  92  - 
mAE 29  14  56 
X  78  -- 
mAE 4  X ~2, del (12) (C1/C2)  54  - 
mAE 22  X  TM, del (12) (E/F1)  74  - 
mAE 32  16  87 
X  87  + 
Meth A(a) 
E36  ++ 
* As determined by the capacity to absorb cytotoxic activity from the Meth A antiserum. 
(++) = absorption comparable to the parental Meth A(a) cells; (+) =  partial absorp- 
tion;(-) = absorption comparable to E36 (see Fig. 1 for examples of individual tests). 
$ The four mouse chromosomes in mAE 17 (MI, M2, Mn, and M4) were rearranged and 
could not be identified by their banding. The numbers refer to chromosomes whose 
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Microcell Hybrids Expressing Meth A Antigen 
HYBRIDS ma 8c, ma  12, mAE  18,  AND mAE 28.  All of these hybrid clones had the 
mouse forms of the enzymes a-galactosidase assigned to the X  chromosome (22)  and 
acid phosphatase  1, mapped on chromosome  12  (23). The karyotype analysis of these 
clones revealed the presence of a  single rearranged mouse chromosome, consisting of 
an intact chromosome  12 attached (at its centromeric region) to the distal end of the 
mouse X  (Fig. 2B and G). The marker was present in 50-85%  of the cells (Table I). 
(The  remaining  cells did not  have  any  mouse  chromosome  material and  probably 
represented segregants that had lost the mouse X  chromosome, but could still survive 
in  HAT  by  virtue  of metabolic  cooperation  with  the  X-retaining  cells.  The  high 
frequency of HPRT-  cells in the population, as revealed by the ease with which back 
selectants were isolated and by the considerably lower plating efficiency of these ceils 
in  HAT  as compared with regular medium,  supports  this interpretation.)  The only 
missing  segment  of chromosome  12  was  part  of its  paracentromeric  region.  The 
translocation resulting in  the  formation of the X 12 chromosome  had  taken  place in 
the parental Meth A(a) line, because  100% of these cells had one to two copies of the 
chromosome (Figs. 2A and 3). (Each Meth A(a) cell had in addition one to two copies 
of normal  chromosome  12  and  X.)  No  other  mouse  chromosome was  found  in  the 
karyotyped hybrid cells or in  200  additional banded metaphases  of each clone that 
were scanned microscopically. 
In contrast to the absorption capacity of hybrids ma 8c, ma  12, and mAE 28  (Fig. 
1A and B), hybrid mAE 18 consistently gave only partial absorption ofMeth A typing 
serum. It is possible that this difference in antigen expression was due to the fact that 
in  mAE  18  the  X x2  translocation  was  found  as  a  single  copy  in  a  predominantly 
tetraploid population, whereas in mAE  28, ma 8c, and  ma  12, one to four copies of 
the marker were present in mostly diploid cells. 
Hybrids ma 8c and ma  12 were switched from HAT  to medium containing 30 #g/ 
ml 6-thioguanine,  in  which  only cells that  had  lost the  mouse X-linked hprt  +  gene 
would survive. The back selectants were collected as a  mass population from two T75 
FIG. 2.  Rearrangements  involving chromosome 12 in the Meth A(a) line and its microcell hybrids 
with  E36: (A)  chromosome  X  TM  and  chromosomes  X  and  12  from  one  Meth  A(a)  cell;  (B) 
chromosome X  TM from hybrid mAE 28; the same chromosome was present in hybrids mAE 18, ma 
8c, and ma 12;  (C) X  TM chromosome from hybrid mAE 22 with deletion of the distal bands 12F1 
and F2; (D) X  TM chromosome from hybrid mAE 4 with deletion of the bands distal to 12C1; (E) 
chromosome 112 from hybrid mAE 6; the normal chromosomes 1 and 12 shown for comparison are 
from one Meth A(a) cell; (F) chromosomes 12  is, 12, and 16 from one Meth A(a) cell; (G) schematic 
representation  of chromosome 12 after Nesbitt and Franke (15) and its rearrangements  in hybrids 
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flasks  (Coming Glass Works,  Corning,  N.  Y.)  within  10  d  of the  beginning of the 
experiment. These cells did not express the antigen. 
HYBRID mAE  6.  This  clone  had  the  mouse  enzymes  peptidase  3,  assigned  to 
chromosome 1 (24), a-galactosidase, and acid phosphatase  1. The karyotype analysis 
showed the presence of a mouse X 1 and a  1  TM translocation in the hybrid cells (Table 
I and Fig. 2E). The rearranged  1  TM chromosome consisted of a mouse chromosome l, 
to the distal end of which (at band H 1) was attached chromosome 12 at its centromeric 
portion. The segment of chromosome 1 distal to H1 was attached to the telomeric end 
of X. The rearrangement had probably arisen soon after the formation of the hybrid 
as a reciprocal translocation between X TM and chromosome 1. 
HYBRID mAE 17.  This clone had four mouse chromosomes in 70-80% of the mostly 
tetraploid population and the mouse forms of the enzymes triosophosphate isomerase, 
assigned to chromosome 6 (25), acid phosphatase 1 (on chromosome 12), peptidase 2, 
assigned to chromosome 10 (26), nucleoside phosphorylase and adenosine kinase, both 
on chromosome 14 (26), and a-galactosidase (on X). All the mouse chromosomes in 
the hybrid were rearranged, and the origin of their material could not be determined 
cytologically, mAE  17 gave partial absorptions comparable to that of mAE 18. 
mAE 32.  Mouse chromosomes X  and  16 were found in 87% of these cells (Table 
I; Fig.  1A). 
Microcell Hybrids Not Expressing Meth A Antigen 
mAE 12.  80% of the cells in this hybrid contained a small fragment with a banding 
pattern corresponding to the proximal half of the mouse X  chromosome (Table I). 
ms 5.  55% of these cells had a normal mouse X  chromosome (and no other mouse 
chromosomes) (Table I). 
mAE  19.  In addition to the mouse X  chromosome, this clone had mouse chromo- 
some 1 (Table I). 
mAE 29.  This hybrid contained mouse chromosomes X  and  14 (Table I). 
mAE 4.  A marker chromosome, derived from the X TM chromosome through deletion 
of the portion of chromosome 12 distal to band C1 was found in 54% of the cells (Fig. 
2D and G; Table I). 
mAE 22.  This clone (Fig.  1A) contained another chromosome marker derived from 
the X TM chromosome through terminal deletion. The breakpoint on chromosome 12 
was at  band  E/F1  (Fig.  2C  and G; Table I). The marker chromosome in mAE 22 
differed from the X TM chromosome in hybrids ma 8c, ma  12, mAE 28, and mAE  18, 
only in the absence of the terminal bands F1 and F1  from chromosome 12. 
Stability of Meth A Antigen Expression by the Microcell Hybrids.  After several weeks in 
culture, all of the microcell hybrids that expressed Meth A  antigen began to show a 
gradual  decline  in  antigenicity.  The  expression  of Meth  A  antigen  by one  of the 
microcell hybrids, mAE 28, was followed for a period of 16 wk. During the first 6 wk, 
the  antigen  was  expressed  at  a  level  sufficient  to  completely absorb  the  cytotoxic 
activity from the typing serum. After that, the absorptions became partial, and after 
10  wk  the  hybrid  was  completely  negative.  At  this  point  the  cells  were  again 
karyotyped,  and  the  X TM  chromosome  was  found  in  80%  of the  cells.  The  only 
difference from the earlier karyotype of mAE 28 was that the population had become 
predominantly tetraploid, whereas when karyotyped the first time, it was diploid. 
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hybrid cell population was always a mixture of X- or X12-containing cells and newly 
arisen segregants, whose proportion depended on the density at which the cells were 
cultured  (a higher density facilitated metabolic cooperation and thus survival of the 
HPRT-  cells).  To  avoid the  density-dependent  fluctuation  in  the  number of X x2- 
containing cells in the population, as well as to avoid the possible negative influence 
of the Chinese hamster genome on the expression of Meth A antigen by the microcell 
hybrids, the Meth A(a)-derived X a2 chromosome was transferred from hybrid mAE 
28 back into mouse cells. Microcells were prepared from mAE 28 at a time when this 
hybrid  had  ceased  to  express  the  Meth  A  antigen  at  a  detectable  level  and  were 
hybridized  with  an  HPRT-  clone of BALB/3T3-THO.  The X 12  marker could  be 
easily identified on the mouse 3T3 background by G-banding. Two of the microcell 
hybrids between mAE 28 and THO (18D/2 and 2T6/7), in which the X 12 chromosome 
was found  intact  in  nearly  100%  of the cells completely absorbed the anti-Meth  A 
cytotoxic activity from the serum (Fig.  1B). Back selection of 18D/2 on 6-thioguanine 
resulted in the loss of the X 12 marker and Meth A  antigen expression  (18D/2  BS in 
Fig.  IB). Two additional mAE 28 ×  THO microcell hybrids, in which the X 12 marker 
had undergone  breakage and was seen intact in <5% of the cells, were negative for 
Meth A antigen. 
Discussion 
To  assign  the  gene  coding  for  the  individually  distinct  Meth  A  antigen  to  a 
particular chromosome, we analyzed somatic cell hybrids of the Meth A sarcoma cell 
lines Meth A(a) and Meth A(s) with the Chinese hamster cell line E36. 
Eight Meth A(a)  ×  E36 and seven Meth A(s)  ×  E36 whole cell hybrids expressed 
Meth  A  antigen  (Fig.  1A),  indicating  that  in  whole  cell  hybrids,  Meth  A  antigen 
expression was not detectably affected by the genome of the Chinese hamster parent. 
In four microcellhybrids (ma 8c, ma  12,  mAE 28, and mAE  18;  Fig.  1 A  and B), 
which  expressed Meth  A  antigen,  the only mouse chromosome present  was an X 12 
translocation, which  they had received from the parental Meth A(a)  cells (Figs.  2 A 
and B, and 3). Hybrid mAE 6, which also expressed the antigen, had chromosomes X 
and  12 in a different arrangement, and in addition, chromosome 1 (Fig. 2 E). Because 
X  and 12 are the chromosomes all these lines have in common, we concluded that one 
or both carry the genetic information necessary for the expression of Meth A antigen. 
As  these  five  lines  were  independently  isolated  clones  and  were  produced  in  two 
separate hybridizations, it was highly unlikely that Meth A antigen expression could 
be due to the presence of a cytologically undetected fragment of some other chromo- 
some that had been co-transferred into and retained by the hybrid cells together with 
the X 12 chromosome. This possibility was further ruled out by the concomitant loss of 
the X 1~ chromosome and Meth A  antigen expression after back selection of hybrids 
ma 8c and ma 12. Another antigen expressing hybrid, mAE  17, had four rearranged 
mouse  chromosomes and  the  enzyme markers  for chromosome 6  (triosophosphate 
FIG.  3.  Karyotype of a  Meth(a) cell. The Meth A(a) cell  line is subtetraploid, most cells having 
chromosome number between 65 and 71. Every cell has 2-4 normal copies of each chromosome; 6- 
10 rearranged telocentric chromosomes; 10-13 biarmed chromosomes, about half of which represent 
Robertsonian  translocations between  normal chromosomes (most often 3.3,  5.5,  9.9,  9.18,  14.15, 
14.19,  17.17);  2-3  are  the  result  of the joining of a  normal  chromosome  (i.e.,  10,  15)  with  a 
rearranged chromosome; and the rest are of unknown chromosome composition. The X 12 and 1216 
chromosomes are present in  100 and 90% of the cells, respectively. 972  GENETIC ANALYSIS OF TUMOR-SPECIFIC ANTIGENS 
isomerase), chromosome 10 (peptidase 2), chromosome 12 (acid phosphatase  1), part 
of chromosome 14 (nucleotide phosphorylase and adenosine kinase, but not esterase 
10), and X  (et-galactosidase). Thus, in agreement with the findings in the other Meth 
A antigen-positive lines, mAE 17 had some material derived from X and chromosome 
12, although its size and location could not be determined. 
Three  lines  containing  a  normal  X  either  as  a  single  chromosome  (ms  5)  or 
accompanied  by chromosome  1  (mAE  19)  or chromosome  14  (mAE  29),  did  not 
express Meth A antigen, mAE 12, which carried a fragment of X, including the hprt 
gene (27), was also negative. The absence of the antigen from the X-containing lines 
indicated that  its expression requires the presence of chromosome 12 in the hybrid 
cells. 
In  two  Meth  A  antigen-negative  hybrids,  the  X 12  chromosome had  undergone 
deletions involving different portions of chromosome 12. In mAE 4, it lacked the part 
distal to band C1  (Fig. 2D and G). In mAE 22, the terminal bands F1 and F2 were 
missing from chromosome  12  (Fig.  2C  and G). The fact that  neither of these lines 
expressed Meth A  antigen indicated that the distal portion of chromosome 12, and 
particularly bands F1 and F2, are essential for antigen expression by the hybrid cells, 
and thus the gene coding for Meth A antigen is probably located in that part of the 
chromosome. Because all antigen-positive lines had X  in addition to chromosome 12, 
it is impossible to rule out some contribution of the X chromosome to Meth A antigen 
expression or requirement  for the presence of both X  and  the  terminal  portion of 
chromosome 12 for a hybrid to be Meth A antigen positive. 
The attachment of chromosome 12 to X  in most of the Meth A antigen-expressing 
hybrids  (ma 8c,  ma  12,  mAE  28,  and  mAE  18)  made  it  possible to maintain  this 
chromosome in a  high percentage of the hybrid population for long period of time. 
Despite this, however, there was a  gradual decline in Meth A  antigen expression by 
the hybrid cells over a period of several months. Repeated karyotype analysis of the 
cells ruled out chromosome breakage or loss  as the cause for this decline. The shift 
from diploidy to tetraploidy that occurred in the mAE 28 hybrid population paralleled 
antigen loss and may have contributed to this change through the increased dosage 
of some  weak  suppressive  factors  present  in  the  Chinese  hamster  cells.  As  was 
mentioned  in  the  previous  section,  hybrids  mAE  17  and  mAE  18,  which  were 
tetraploid when analyzed for the first time, had lower levels of the antigen compared 
with the diploid X12-containing hybrids. 
To eliminate the presumed negative influence of the Chinese hamster genome on 
the expression of Meth A  antigen, we transferred the X TM chromosome from hybrid 
mAE 28 (when it no longer expressed Meth A antigen) into an HPRT- BALB/3T3 
clone,  THO.  Two  microcell  hybrids,  which  contained  the  X TM  chromosome on  a 
BALB/3T3 background,  expressed the  Meth  A  antigen  (Fig.  1 B).  Although  these 
results are consistent with the idea that  factors adversely affecting Meth A  antigen 
expression are present in the microcell hybrids, the nature and mechanism of action 
of these factors remain unclear. 
Surprisingly,  hybrid  mAE  32,  in  which  the  karyotype analysis  revealed  mouse 
chromosomes X  and  16 and  no identifiable chromosome  12-derived material,  also 
expressed  the  Meth  A  antigen  (Fig.  1 A).  There  are  several  ways  to  explain  the 
discrepancy between this finding and the assignment of the Meth A gene to the distal 
portion of chromosome 12 on the basis of the data discussed above. First, the mouse PRAVTCHEVA, DELEO, RUDDLE, AND OLD  973 
chromosomes in the microcell hybrids showed a  pronounced tendency for fragmen- 
tation, as demonstrated by the deletions in mAE 22, mAE4, and mAE 12, and by the 
rapid disappearance of any whole mouse chromosomes from most of the cells in 73% 
of the hybrids. Thus, it is conceivable that  mAE 32 early in  its history could have 
had, in addition to X  and chromosome 16, a chromosome 12, a small piece of which 
remained integrated somewhere in the Chinese hamster chromosomes. The presence 
of a  12  a~ translocation (Figs.  2 F  and 3)  in 90% of the Meth A(a) cells increases the 
probability of the introduction of both chromosomes 12 and  16 in the hybrid  (the 
apparently normal  16 being derived from the  12  a6 translocation). Second, molecules 
carrying Meth A determinants could be encoded by more than one locus, one of them 
at  the  terminal  part  of 12  and  another one on  16.  A  third  possibility,  which  we 
consider much less likely, is that the Meth A  gene is located on X, the chromosome 
that ma 8c, ma  12, mAE 28, mAE  18, mAE 6, and mAE 32 have in common. The 
negative absorptions by five hybrid lines containing X either as a separate chromosome 
or as part of a  deleted X 12 marker (ms 5, mAE  19, mAE 29, mAE 4, and mAE 22) 
would have to be explained by the rapid turning off of the antigen, which made it 
undetectable by the  time these  lines were  first  available  for analysis.  As  discussed 
above,  the  antigen-positive  lines  showed  a  decrease  in  antigenicity  unrelated  to 
chromosome loss over a  period of several months. Whatever the mechanisms of this 
decline, it would have to be assumed that for unknown reasons it had proceeded at a 
much faster rate in the five X-containing lines in order to explain their negativity in 
the first two to four passages (1-2 wk) after isolation. 
We found no evidence for linkage between the Meth A  coding gene and the H-2 
complex. One of the current hypotheses regarding the nature of TSA is  that  they 
represent altered H-2 products or abnormally expressed alien H-2 specificities, on the 
basis  of the  model  for the H-2 complex proposed by Bodmer (28).  In some cases, 
abnormal expression of alien H-2 specificities by tumor cells has been documented 
(29, 30). However, the molecules carrying the alien H-2 specificities are distinct from 
the TSA of the tumor (31). None of our hybrids that expressed Meth A antigen had 
either  a  cytologically recognizable  mouse  chromosome  17  (which  carries  the  H-2 
complex) or expressed the mouse form of glyoxalase  1, assigned to chromosome 17 
(32).  This is in agreement with the results of Natori et al.  (33), indicating that  the 
solubilized Meth A-specific transplantation antigen (which seems to be related to the 
serologically defined Meth A TSA [10])  is distinct from the H-2 products. Klein and 
Klein (34) also found no correlation between the presence of chromosome 17 and the 
expression of the TSA by somatic cell hybrids of an MCA-induced mouse sarcoma. 
The assignment of the Meth A gene to chromosome 12, and possibly 16, indicates 
linkage of this TSA with gene clusters encoding the immunoglobulin (Ig) heavy chains 
and  ~k  light  chains.  The  heavy chain  genes  were  assigned  to  chromosome  12  by 
Hengartner et al.  (35)  and D'Eustachio et al.  (36).  Two of the hybrids described in 
this paper (mAE 28 and mAE 4) were analyzed by Southern blotting for the presence 
of the  mouse  C  y2b  and  C  /x  DNA  sequences  (36).  Mouse  restriction  fragments 
hybridizing with the cloned eDNA probes were present in mAE 28, but absent from 
mAE 4. On the basis of this, it was concluded that the mouse heavy chain gene cluster 
is located on the portion of chromosome 12 distal to band C1. Meo et al. (37) further 
localized the 3,2a gene on the telomeric portion of chromosome 12, proximal to and 
closely linked to the break point in band  12 F1 in the (12,5)  translocation studied by 974  GENETIC ANALYSIS OF TUMOR-SPECIFIC ANTIGENS 
them.  Thus,  the  Ig  heavy  chain  gene  cluster  is  located  in  the  same  region  of 
chromosome 12, which was found to be necessary for Meth A antigen expression by 
the  hybrids  (bands  F1-F2).  The  ~  light  chain  genes  were  recently  mapped  to 
chromosome  16  by  DNA  restriction  analysis  of a  panel  of somatic  cell  hybrids, 
including mAE 32 by D'Eustachio et al.  (38). 
On the basis of the close linkage of this TSA with the Ig heavy chain and possibly 
with the ~k light chain genes, it is tempting to speculate that the genetic elements used 
to generate the enormous variety of the Ig idiotypes (the antigenic determinants on 
the  variable portion  of the  molecule)  are  also  involved in  the  generation of TSA 
diversity. The genes encoding the variable and constant region of the Ig heavy and 
light chains exist as separate elements that are recombined and thus made functional 
(with respect  to Ig production)  in  the process of B  cell development  (39-42).  The 
variable gene-encoded portion of the Ig molecule has the ability to recognize specific 
antigenic  determinants,  whereas  the  constant  region  carries  an  effector function 
common to a given class of Ig. The relative independence of recognition and effector 
parts is further demonstrated by the mounting evidence for the presence of variable 
gene-encoded antigenic determinants  (idiotypes) on molecules other than immuno- 
globulins, such as receptors and antigen-specific regulatory products ofT lymphocytes 
(43-48). One might speculate that the expression of the variable genes is not limited 
to the cells of the immune system, but has a  much broader use by various somatic 
cells.  Through the variable genes (possibly different subsets of them), the ability to 
recognize a  specific structure could be transferred to other molecules, with different 
consequences  of  the  recognition  event  for  the  cell.  Some  of  these  hypothetical 
molecules might be involved in the interactions controlling cell growth and differen- 
tiation. 
If this is the case, TSA would be expected to be found in normal cells before the 
induction of malignant transformation. The fact that  they remain unrecognized by 
the animal's immune system could be a result of (a) restricted occurrence in a small 
population of cells, (b) very low levels on normal cells, (c) predominantly intracellular 
localization, and  (d) interactions with other molecules that mask its antigenic deter- 
minants, or any combination of these factors. Accordingly, malignant transformation 
would elicit immune reaction against  TSA by significantly expanding a  previously 
small population, by increasing the amount of the antigen per cell, by changing its 
distribution among the cellular compartments, and/or unmasking the TSA determi- 
nants.  If it  is  further  postulated  that  each  cell  is  irreversibly committed  to  the 
expression of a single TSA, it would be difficult to reconcile this hypothesis with the 
observations  of Basombrio  and  Prehn  (5)  and  Embleton  and  Heidelberger  (6), 
indicating that  subpopulations of recently derived clones express non-cross-reacting 
TSA after in vitro transformation. However, if a cell can express several TSA at any 
given  time  of its  life history  (and  a  transformation  event  results  in  the  increased 
amounts of one of them), or if the cells express different TSA sequentially as they 
continuously undergo differentiation and maturation, such a lack of cross-reacting is 
to be expected. 
Summary 
Chemically induced sarcomas of inbred mice express antigens that are distinct and 
specific for each individual tumor. Chromosome assignment of tumor-specific antigens PRAVTCHEVA,  DELEO, RUDDLE,  AND OLD  975 
would help to elucidate the genetic basis of their diversity.  Expression of the serolog- 
ically defined Meth A  sarcoma antigen is not suppressed in hybrid cells containing a 
complete  foreign  (Chinese  hamster)  genome.  Chromosome and serologic analysis of 
microcell  hybrids between  Meth A  sarcoma cells and Chinese hamster cells shows a 
clear correlation of Meth A  antigen expression with the presence of the distal  region 
of chromosome  12  (bands F1  and F2). Chromosome 16 may also be implicated.  The 
significance of the close linkage of genes determining Meth A antigen expression with 
the  immunoglobulin  heavy chain  gene cluster  (on chromosome  12)  and  the X light 
chain genes (on chromosome 16) is discussed. 
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